A partial differential equation model of metastasized prostatic cancer
Biochemically failing metastatic prostate cancer is typically treated with androgen ablation. However, due to the emergence of castration-resistant cells that can survive in low androgen concentrations, such therapy eventually fails. Here, we develop a partial differential equation model of the grow...
Saved in:
Main Authors: | Avner Friedman, Harsh Vardhan Jain |
---|---|
Format: | Article |
Language: | English |
Published: |
AIMS Press
2013-03-01
|
Series: | Mathematical Biosciences and Engineering |
Subjects: | |
Online Access: | https://www.aimspress.com/article/doi/10.3934/mbe.2013.10.591 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Specific immunohistochemical expression of Mmp-26 in prostatic adenocarcinoma
by: ROMILDO LUCIANO DA SILVA, et al.
Published: (2025-01-01) -
Analysis of the predictive value of the prostate-specific antigen-to-neutrophil ratio for the diagnosis of prostate cancer
by: Yuxuan Chen, et al.
Published: (2025-01-01) -
Current biomarkers of prostate cancer
by: I. A. Aboian, et al.
Published: (2021-12-01) -
Value of Systematic and MRI‐Ultrasound Fusion Prostate Biopsy in Different Prostate Specific Antigen (PSA) Levels
by: Solmaz Ohadian Moghadam, et al.
Published: (2025-01-01) -
Focal Therapy for Prostate Cancer: Recent Advances and Insights
by: Francesco Lasorsa, et al.
Published: (2024-12-01)